SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-151490
Filing Date
2017-05-01
Accepted
2017-05-01 14:55:57
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d377068d10ka.htm 10-K/A 446141
2 EX-31.3 d377068dex313.htm EX-31.3 2650
3 EX-31.4 d377068dex314.htm EX-31.4 2595
  Complete submission text file 0001193125-17-151490.txt   452418
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35409 | Film No.: 17800150
SIC: 2834 Pharmaceutical Preparations